CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01076348
NCT01076348N/ACompleted
CompareCT.gov

Medtronic Model 4965 Capsure Epi® Steroid-eluting Unipolar Epicardial Pacing Lead Post Approval Study

Medtronic·observational·Posted Feb 26, 2010·Updated Feb 27, 2019

In Brief

An observational study for Heart Failure and 3 related conditions. Completed, enrolled 73 participants across 107 sites in 14 countries.

Detailed Summary

Safety and effectiveness will be summarized for the model 4965 lead. This study was conducted within Medtronic's System Longevity Study (SLS).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Pacing, Bradycardia, Arrhythmia
CountriesAustralia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Serbia, Spain, Sweden, Switzerland, United States
Collaborators--

Timeline

N/ACompletedFinished
19961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 26, 2010
Enrollment StartSep 1, 1996
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 14.6 yearsPosted 16.3 years ago